Re: intravenous versus oral busulfan--perhaps not as different as suggested.
Slattery
John T
JT
D000284:Administration, Oral; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000633:toxicity; D019540:Area Under Curve; D002066:Busulfan / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000633:toxicity*; D019337:Hematologic Neoplasms / Q000150:complications / Q000188:drug therapy / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods; D006504:Hepatic Veno-Occlusive Disease / Q000139:chemically induced; D006801:Humans; D007275:Injections, Intravenous
D018906:Antineoplastic Agents, Alkylating; D002066:Busulfan